Biotech · Private company
Cloudbreak Therapeutics, LLC
Track this companyFree. Adds Cloudbreak Therapeutics, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- CBT-001Phase 3 · PterygiumClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 3 · PterygiumClinicalTrials.gov · fetched Nov 12, 2026
- CBT-001 Multi-dosePhase 2 · PterygiumClinicalTrials.gov · fetched Nov 12, 2026
- CBT-001 single dosePhase 2 · PterygiumClinicalTrials.gov · fetched Nov 12, 2026
- CBT-004Phase 2 · PingueculaClinicalTrials.gov · fetched Nov 12, 2026
- CBT-006Phase 2 · Meibomian Gland DysfunctionClinicalTrials.gov · fetched Nov 12, 2026
- CBT-008Phase 2 · Meibomian Gland DysfunctionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Safety and Efficacy Study of CBT-004 in Patients With Vascularized PingueculaPHASE2 · COMPLETED · started Dec 21, 2023ClinicalTrials.gov NCT04884256 · fetched Nov 12, 2026
- A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With PterygiumPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 30, 2022ClinicalTrials.gov NCT05456425 · fetched Nov 12, 2026
- Safety, Efficacy and Pharmacokinetics of CBT-008 in Patients With Meibomian Gland DysfunctionPHASE2 · COMPLETED · started Mar 4, 2022ClinicalTrials.gov NCT05261386 · fetched Nov 12, 2026
- Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland DysfunctionPHASE2 · COMPLETED · started Sep 5, 2021ClinicalTrials.gov NCT04884243 · fetched Nov 12, 2026
- Safety and Efficacy of CBT-001 Ophthalmic Solution in Patients With PterygiumPHASE2 · COMPLETED · started Apr 15, 2017ClinicalTrials.gov NCT03049852 · fetched Nov 12, 2026